Emcure Pharmaceuticals Ltd.
EMCURE Share PricePharmaceuticals & Drugs
₹1,354.3
-18.4 (-1.3%)
As on September 8, 2025
Exchange Scrips: BSE544210NSEEMCUREISININE168P01015
Market Cap ₹ 25,713 Cr
P/E Ratio 37.66
Dividend Yield N/A
Performance
Market performance
Open1,378
High1,399
Volumes57,836
Prev1,354.3
Low1,347.3
As on2025-09-08
Historical performance
1 Year High1,580
3 Year High1,580
5 Year High1,580
1 Year Low889
3 Year Low889
5 Year Low889
Fundamentals
Company Valuation
Market Cap (₹Cr)
25,713
Face Value (₹)
10
P/E Ratio
37.66
Dividend Yield
N/A
Investment Returns
1 Year
-2.9%
3 Years
N/A
5 Years
N/A
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 1,366.84 | Bearish |
| 10-DMA | 1,400.32 | Bearish |
| 20-DMA | 1,424.36 | Bearish |
| 50-DMA | 1,380.6 | Bearish |
| 100-DMA | 1,288.08 | Bullish |
| 200-DMA | 1,244.89 | Bullish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|
| Promoters | 20 | 20 | 20 | 20 |
| Foreign Investors | 2 | 2 | 2 | 2 |
| Domestic Investors | 18 | 18 | 18 | 18 |
| Public Investors | 133529 | 139651 | 143429 | 152894 |
| Government | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 37.66.
- 3Y Stock Price CAGR of the stock is -0.4.
- The stock has a beta of 1.2.
- In the last financial year, the company had an EBITDA of ₹15416 Million.
- The company generated revenue of ₹78960 Million in the previous financial year.
Emcure Pharmaceuticals Ltd.
1354.3-18.4 (-1.3%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 973791.1
No. of Shares: 719 (Approx)
Performance:-2.6%
P/L: ₹-26208.9
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent